v3.25.2
Basis of Presentation and Significant Accounting Policies and Estimates (Narrative) (Details)
3 Months Ended 6 Months Ended
Jan. 27, 2025
USD ($)
$ / shares
shares
Jun. 30, 2025
$ / shares
shares
Mar. 31, 2025
USD ($)
$ / shares
Jun. 30, 2024
$ / shares
Jun. 30, 2025
$ / shares
shares
Jun. 30, 2024
$ / shares
Dec. 31, 2024
shares
Financing Receivable, Past Due [Line Items]              
Increase in ACL for loans | $     $ 37,000        
Gross proceeds | $ $ 49,500,000            
Common stock issued | shares 4,950,460 6,836,514     6,836,514   6,836,514
Common stock per share | $ / shares $ 10            
Exchange ratio 1.3549            
Common stock outstanding | shares   5,759,172     5,759,172   5,735,226
Dividends declared per share | $ / shares   $ 0 $ 0.18 $ 0.18 $ 0.18 $ 0.18  
Stock Offering [Member]              
Financing Receivable, Past Due [Line Items]              
Common stock outstanding | shares 7,825,501            
O 2025 Q2 Dividends [Member]              
Financing Receivable, Past Due [Line Items]              
Dividends declared per share | $ / shares         $ 0.09    
Dividends payable, date of paid         Aug. 13, 2025    
Dividends payable, date of record         Aug. 04, 2025    
Unfunded Loan Commitment [Member]              
Financing Receivable, Past Due [Line Items]              
Increase in the reserve for finance receivables | $     $ 9,000